Accumulated Laboratory Data in B12 Vitamin Blood Level Time Dependency Studies in Patients with Myeloma, Lymphocytic Leukemia and Myeloblastic Leukemia in Latvia

Didzis Gavars, Agris Auce, Eriks Tauckels, Agnese Miķelsone, Anna Inese Tutane

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

4 Downloads (Pure)

Abstract

Vitamin B12 blood level in patients with myeloma (C90 - International Classification of Diseases (ICD-10)), lymphocytic leukemia (C91) and myeloblastic leukemia (C92) prior and after the diagnosis and also BCR-ABL (fusion gene from breakpoint cluster region BCR gene and tyrosine-protein kinase ABL1 (Abelson murine leukemia) gene) tests for C92 patients were studied. Clinical records of 20 C92 patients in Riga East University Hospital were complemented with 6987 B12 clinical test data accumulated in E Gulbis laboratory (EGL) for 7451 patients over 20 years period. BCR-ABL and B12 dynamics for 11 patients with sufficient number of BCRABL and B12 tests were studied. Oracle Cloud with pseudonymized data replica from more than 350 000 000 original EGL clinical test data was used. The data were selected by online analytical processing and SQL built in tools and then used in offline analysis and visualization. Annually there are 107, 189 and 91 confirmed cases of C90, C91 and C92 in Latvia. EGL has 30% more C90-92 patients, due to suspected but later unconfirmed cases. Out of 7451 patients 1386 had one B12 test, two- 548, three and more- 864. The patients with diagnosis fluctuating between C90, C91 and C92 were excluded from the study. The data for the time period of 10 years before and after the first diagnosis were analyzed. Results. Methods and tools for data extraction and analysis from large amount of archived clinical test data were developed and applied. High and very high B12 level was observed for 53% of C92 patients starting from 3 years prior to diagnosis. For C90 and C91 patients B12 level changes around the diagnosis date were also observed although the effect was considerably smaller. Analysis of 11 selected patient data with clinical records showed timewise correlation between B12 and BCR-ABL for 3 of the patients.

Original languageEnglish
Title of host publicationVide. Tehnoloģija. Resursi : XIV starptautiskās zinātniski praktiskās konferences rakstu krājums
Subtitle of host publicationEnvironment. Technology. Resources : Proceedings of the 14th International Scientific and Practical Conference
Place of PublicationRēzekne
PublisherRezekne Higher Education Institution
Pages34-39
Number of pages6
Volume2
ISBN (Electronic)9781713874881
DOIs
Publication statusPublished - 2023
Externally publishedYes
Event14th International Scientific and Practical Conference on Environment. Technology. Resources. - Rezekne Academy of Technologies, Rezekne, Latvia
Duration: 15 Jun 202316 Jun 2023
Conference number: 14
https://conferences.rta.lv/index.php/ETR/ETR2023

Publication series

NameVide. Tehnologija. Resursi - Environment, Technology, Resources
PublisherRezekne Higher Education Institution
Volume2
ISSN (Print)1691-5402
ISSN (Electronic)2256-070X

Conference

Conference14th International Scientific and Practical Conference on Environment. Technology. Resources.
Abbreviated titleETR 2023
Country/TerritoryLatvia
CityRezekne
Period15/06/2316/06/23
Internet address

Keywords*

  • B12 vitamin
  • laboratory data
  • lymphocytic leukemia
  • myeloblastic leukemia
  • myeloma

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.1. Articles or chapters in proceedings/scientific books indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Accumulated Laboratory Data in B12 Vitamin Blood Level Time Dependency Studies in Patients with Myeloma, Lymphocytic Leukemia and Myeloblastic Leukemia in Latvia'. Together they form a unique fingerprint.

Cite this